Ameritas Investment Partners’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.9K | Hold |
8,321
| – | – | ﹤0.01% | 2300 |
|
|
2025
Q1 | $53.9K | Hold |
8,321
| – | – | ﹤0.01% | 2062 |
|
|
2024
Q4 | $61.1K | Hold |
8,321
| – | – | ﹤0.01% | 2064 |
|
|
2024
Q3 | $62.3K | Hold |
8,321
| – | – | ﹤0.01% | 2066 |
|
|
2024
Q2 | $74.1K | Hold |
8,321
| – | – | ﹤0.01% | 1918 |
|
|
2024
Q1 | $84.3K | Hold |
8,321
| – | – | ﹤0.01% | 1849 |
|
|
2023
Q4 | $83.7K | Hold |
8,321
| – | – | ﹤0.01% | 1857 |
|
|
2023
Q3 | $78K | Buy |
8,321
+1,405
| +20% | +$13.2K | ﹤0.01% | 1826 |
|
|
2023
Q2 | $170K | Buy |
6,916
+1,113
| +19% | +$27.3K | 0.01% | 1242 |
|
|
2023
Q1 | $135K | Hold |
5,803
| – | – | 0.01% | 1327 |
|
|
2022
Q4 | $169K | Buy |
5,803
+364
| +7% | +$10.6K | 0.01% | 1248 |
|
|
2022
Q3 | $104K | Hold |
5,439
| – | – | ﹤0.01% | 1464 |
|
|
2022
Q2 | $138K | Buy |
5,439
+726
| +15% | +$18.4K | 0.01% | 1287 |
|
|
2022
Q1 | $121K | Hold |
4,713
| – | – | ﹤0.01% | 1510 |
|
|
2021
Q4 | $197K | Hold |
4,713
| – | – | 0.01% | 1247 |
|
|
2021
Q3 | $205K | Hold |
4,713
| – | – | 0.01% | 1185 |
|
|
2021
Q2 | $223K | Buy |
4,713
+355
| +8% | +$16.8K | 0.01% | 1165 |
|
|
2021
Q1 | $223K | Sell |
4,358
-208
| -5% | -$10.6K | 0.01% | 1139 |
|
|
2020
Q4 | $122K | Hold |
4,566
| – | – | 0.01% | 1455 |
|
|
2020
Q3 | $157K | Buy |
4,566
+476
| +12% | +$16.4K | 0.01% | 1167 |
|
|
2020
Q2 | $168K | Buy |
4,090
+3,470
| +560% | +$143K | 0.01% | 1092 |
|
|
2020
Q1 | $21K | Hold |
620
| – | – | ﹤0.01% | 2158 |
|
|
2019
Q4 | $8K | Buy |
+620
| New | +$8K | ﹤0.01% | 2813 |
|